Inventor
Fenghuang Zhan
Inventor
Little Rock, AR, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology12%
Y02ATechnologies for adaptation to climate change12%
G06FElectric digital data processing9%
A61KPreparations for medical, dental or toiletry purposes3%
A61NElectrotherapy3%
PatentTitleYear
10,597,729Use of gene expression profiling to predict survival in cancer patient202010,577,656Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling202010,052,304Compositions and methods for cancer therapy20189,714,451'Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling'20179,650,677'Use of gene expression profiling to predict survival in cancer patient'20179,574,238'Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling'20178,954,283'Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling'20158,843,320'Use of gene expression profiling to predict survival in cancer patient'20147,983,850'Diagnosis, prognosis, identification, and classification of multiple myeloma based on gene expression profiling'20117,935,679'Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myeloma'20117,894,992'Diagnosis and classification of multiple myeloma'20117,741,035'Use of gene expression profiling to predict survival in cancer patient'20107,668,659'Diagnosis and classification of multiple myeloma'20107,371,736'Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss'20087,308,364'Diagnosis of multiple myeloma on gene expression profiling'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2014Based in Little Rock, AR, US· patent location history
2008–2017Patents assigned to UNIV ARKANSAS (10)· patent assignee history
2014–2015Patents assigned to BARLOGIE BART (2)· patent assignee history
2014–2015Patents assigned to ZHAN FENGHUANG (2)· patent assignee history
2014Patents assigned to SHAUGHNESSY JOHN D (1)· patent assignee history
2015–2020Based in Salt Lake City, UT, US· patent location history
2017–2020Patents assigned to BIOVENTURES LLC (3)· patent assignee history
2018Based in Iowa City, IA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV ARKANSAS | 10 | 2008–2017 |
| BIOVENTURES LLC | 3 | 2017–2020 |
| BARLOGIE BART | 2 | 2014–2015 |
| ZHAN FENGHUANGself | 2 | 2014–2015 |
| SHAUGHNESSY JOHN D | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Little Rock, AR, US | 8 | 2007–2014 |
| Salt Lake City, UT, US | 6 | 2015–2020 |
| Iowa City, IA, US | 1 | 2018 |